Clinical trials recruiting in Sejong, South Korea

Phase breakdown

Conditions recruiting in Sejong, South Korea

Recruiting trials in Sejong, South Korea

• A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
  NCT06246123 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• MRI-Based Prediction of Dienogest Response in Endometriosis
  NCT07446608 · Phase: Not specified · Ages: 19 Years to 45 Years · Sex: Female
• Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction
  NCT05490433 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years to 70 Years · Sex: Female
• Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
  NCT07221851 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Sejong, South Korea?

4 recruiting trials have at least one study site in Sejong, South Korea.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.